RxDoctor Payments Data

Lowell Tong, DPM

Foot & Ankle Surgery · Aiea, HINPI 1023672979

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Kairos Surgical Inc at 46.9% of the total.

$10,326in general payments, 2019–2025

Across 55 payments — averaging $187.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$5K
  • Arthrex$3K
  • Elevate Surgical Co$1K
  • Smith+Nephew$304
  • Integra Lifesciences Corporation$186
  • Stryker$185
  • plus $685 from 8 others

What the payments were for

  • Speaking & faculty fees$2,50024%
  • Travel & lodging$1,24812%
  • Food & beverage$1,79617%
  • Education$4,78246%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kairos Surgical Inc8$4,848
Arthrex7$3,034
Elevate Surgical Co7$1,083
Smith+Nephew16$304
Integra Lifesciences Corporation5$186
Stryker3$185
Galt Pharmaceuticals, LLC1$182
Carbofix Orthopedics Inc1$138
Fusion Orthopedics USA, LLC1$125
Kowa Pharmaceuticals America, Inc.1$125
Bioventus LLC2$54
Tactile Systems Technology Inc1$24
Paragon 28, Inc.1$22
Medline Industries LP1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few foot & ankle surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$53,452
Medicare patients
120
Services billed
608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$415
Cephalexin13$113
Doxycycline Hyclate13$96

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Aiea

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →